chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Taste disorder
Clinical narrative: had an anxiety attack/the anxiety attack was really out of the ordinary; had a horrible panic attack/having hot fiery panic attacks; bad taste in the mouth; couldn't sleep real well/she can fall asleep, but she cant stay asleep, she recalls on the first night after getting the vaccine, on 19Feb2021 she would wake up every hour; her hands are clammy, she is sweating; her hands are clammy, she is sweating; This is a spontaneous report from a contactable consumer (patient herself). A 62-year old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via unspecified route of administration in the left arm on 19Feb2021 (Batch lot number EN6200) (at the age of 62-year old) at single dose for Covid-19 immunization and alprazolam (XANAX XR) orally at 2 mg in the morning at 6 AM and 1 mg at 1 PM (3 mg daily total) for anxiety. She actually had 2 separate prescriptions: one was a Xanax Extended Release 2 mg pill, and the other was a Xanax Extended Release 1mg pill. Relevant medical history included breast cancer from 2006, high blood pressure and cholesterol abnormal. Concomitant drugs included medication for high blood pressure and cholesterol medication. The patient reported that usually her anxiety was managed by medicine, however after the shot, Friday at noon, it was weird she had a horrible panic attack. She also had the panic attack Sunday, yesterday, and a little today. Her anxiety was always controlled prior to the first dose of vaccine but after the shot, it wass not, her anxiety was out of control. She noticed her anxiety incident probably Saturday morning around 6 AM. She did have complications on Friday 19Feb2021, it was a bad taste in the mouth and she couldn't sleep real well at night. She clarified that she can fall asleep, but she cant stay asleep, she recalled on the first night after getting the vaccine, on 19Feb2021 she would wake up every hour. Anxiety was not controlled: it would say being controlled by her medicine as far as intensity of the anxiety attack. On Saturday and Sunday was the biggest anxiety attack, and it was as if she was not even on the medication that's what it felt like, she was not better, the anxiety was still there. Like during the panic attack her hands were clammy, she was sweating, its an anxiety attack, it could be hormones. This was like as if she was not even taking her Xanax XR, she was having hot fiery panic attacks. She just had a physician appointment 2 weeks before the report (and before the vaccination) and everything was fine: "perfectly fine". The outcome of bad taste was recovering, the outcome of sleep unwell was not recovered while the outcome of the other events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Analgesic drug level, Apnoeic attack, C-reactive protein, Electrocardiogram abnormal, Endotracheal intubation
Clinical narrative: Patient presented hyperventilating, tachycardic and eventually became apneic and required intubation; had COVID in the past; was COVID IgG positive; troponin normal; ECG sinus tachycardia; all other labs normal on 5/22 and 5/23
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count, Hyperventilation, Laboratory test, Metabolic function test, SARS-CoV-2 test positive
Clinical narrative: Patient presented hyperventilating, tachycardic and eventually became apneic and required intubation; had COVID in the past; was COVID IgG positive; troponin normal; ECG sinus tachycardia; all other labs normal on 5/22 and 5/23
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Sinus tachycardia, Tachycardia, Toxicologic test, Troponin normal
Clinical narrative: Patient presented hyperventilating, tachycardic and eventually became apneic and required intubation; had COVID in the past; was COVID IgG positive; troponin normal; ECG sinus tachycardia; all other labs normal on 5/22 and 5/23
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: mild/moderate stabbing pain at sternal notch when swallowing starting approx. 3 hours after vaccination, lasted approx. 3 weeks, resolved spontaneously.  Did not seek eval/care when symptomatic.  no dysphagia to liquid/solid. No airway compromise.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Headache, Hypertension
Clinical narrative: blood pressure has been consistently high/ in crisis mode; Severe headache; This is a spontaneous report received from a contactable consumer (patient). A 46-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EN6201), via an unspecified route of administration in left arm on 19Feb2021 at 03:45 PM as first dose, single dose for covid-19 immunisation. Medical history included patient had known allergies. The patient received other medications in two weeks (Unspecified). The patient did not receive any other vaccines within four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. One-week post vaccination, on 26Feb2021 at 07:30 AM patient experienced severe headache and elevated blood pressure readings. Blood pressure was been consistently high ever since and now she was on medication to try to control it. Patient had normal BP readings prior to getting the vaccine on an unspecified date. Now patient was in crisis mode trying to avoid a stroke. The event resulted in visit to doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received treatment of blood pressure medication due to the elevated blood pressure. Since the vaccination, the patient hasn't been tested for COVID-19. The patient underwent lab tests and procedures which included blood pressure: normal (prior to getting the vaccine) on an unspecified date and blood pressure: elevated on 26Feb2021. The outcome of the events was not recovered.  No follow-up attempts are possible; no further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: fatigue; This is a spontaneous report from a contactable pharmacist. This pharmacist reported for a 41-year-old female patient who received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unknown date as 2nd dose, single dose (at 41-year-old) for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine of the patient included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an 18Dec2020 as 1st dose, single dose (at 41-year-old) for COVID-19 immunization and experienced fatigue and nausea on 18Dec2020. On an unknown date the patient experienced fatigue. The outcome of the event recovered on an unspecified date.   Information on the Lot/Batch Number has been requested. Follow-up attempts were completed. No further information was expected.
Sex: F
Vaccine: COVID19
Symptoms: Deafness, Tinnitus, Vertigo
Clinical narrative: tinnitus with hearing loss; tinnitus with hearing loss; vertigo and tinnitus with hearing loss; This is a spontaneous report received from a contactable consumer (patient). Follow-up (05Mar2021) information was processed together with initial information. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date was not reported) via an unspecified route of administration, on an unknown date, as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications was not reported. On an unknown date, a week later actually, the patient had vertigo and tinnitus with hearing loss. She had received a steroid injection into the ear and her second Covid dose is Friday. She stated do you have an opinion on this matter. Caller was on her way to receive the second dose of the Pfizer Covid 19 vaccine. She wants to know if there could be any interactions from the steroids and the vaccine. Outcome of the events was reported as unknown.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Hyperhidrosis, Pain, Pyrexia, Wheezing
Clinical narrative: congested, coughing; wheezing a little; Warmness; A wet forehead; achy all over; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 85-years-old female patient received first dose of bnt162b2 (BNT162B2, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as 1st DOSE SINGLE DOSE for covid-19 immunization. Patient medical history included asthma from an unknown date and unknown if ongoing, pneumonia from an unknown date and unknown if ongoing, cough from an unknown date and unknown if ongoing , nasopharyngitis from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced congested, coughing wheezing, warmness, a wet forehead, achy all over on 08Mar2021 with outcome of unknown.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: she had chronic diarrhea for a week which started in less than 24 hours after receiving the vaccine and just got better this last weekend; This is a spontaneous report from a contactable Nurse. This (Age-, Unit-unknown) female Nurse (Patient) reported that:  Primary source of information: Reporter Qualification: Other Health Reporter Correspondence Contact: False  Patient characteristics:  Sex:   Reaction/Event: MedDRA version for reaction/event term LLT: N/A Reaction/event in MedDRA terminology (LLT): Medical Information Potential AE   Drug Information: Characterization of drug role: (Suspect) Proprietary medicinal product name: Pfizer-Biontech Covid-19 Vaccine    Identification of the country where the drug was obtained:  Country of authorization/application:   Active Substance Information: Active Drug substance names: Pfizer-Biontech Covid-19 Vaccine     Narrative case summary and further information:  Case narrative: Originating AE Request: REQ # Attachments: 1 Patient Age:  Reporter Subtype: Nurse PQC Present: No AE Present: Yes  PQC Details: Request Name: REQ # Product: PFIZER-BIONTECH COVID-19 VACCINE Question: Caller is confirming if there is latex in the stopper of the vial. They were informed by the pharmacist administering the vaccine that there was no latex in the stopper of the vial. She mentioned that she worked with the (Hospital name) in (location withheld) in which they would pop the top off the vial if the patient is allergic to latex. She would also like to know what material the stopper is made from.  Request Name: REQ # Product: PFIZER-BIONTECH COVID-19 VACCINE Question: Nice to know that Pfizer is no longer using latex in their vaccines.  Request Name: REQ # Product: PFIZER-BIONTECH COVID-19 VACCINE Question: You were very helpful. Thank you for confirming and making me understand my concern.  Request Name: REQ # Product: PFIZER-BIONTECH COVID-19 VACCINE Question: Caller mentioned that she and her husband both received the 1st dose of the vaccine on 26Feb2021 and experienced side effects. Her husband, (name withheld), aged , experienced a low grade fever with temperatures going up to 99 degree F (his usual temperature is 98 degree F) that lasted for about 24 hours. The next day he went to the ER because of chest pain, but they attribute it to his long heart history. The caller mentioned that she had chronic diarrhea for a week which started in less than 24 hours after receiving the vaccine and just got better this last weekend. She is not sure if this is related to the vaccine.  Caller refused transfer to safety as she was busy. E-transferring to department, Possible AE DUplicate. Caller mentioned that she would be happy to provide more information upon follow up.  Request Name: REQ # Product: PFIZER-BIONTECH COVID-19 VACCINE Question: The general public needs to know anything that would trigger a possible severe reaction with the vaccine. Specifically the allergens in your vaccines.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dizziness
Clinical narrative: patient began to experience lightheadedness/Related Anxiety; Vaccine- Related Anxiety; This is a spontaneous report from a non-contactable Health Care Professional. A 65-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6204, Expiration date: Not reported), via an unspecified route on unspecified date as 1ST DOSE, SINGLE DOSE for COVID-19 IMMUNISATION. The patient medical history and concomitant medications were not reported. On unspecified date (15 minutes after vaccination), the patient experienced light headedness. Also reported She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, dizziness, facial swelling, lip swelling and tongue swelling .The patient received treatment included water and on follow up response to treatment was excellent. It was reported that patient is stable to go home and discharged. It was reported that follow up with PCP as needed and the differential diagnosis: Vaccine- Related Anxiety (include misc mental health) observed for 15 minutes in the bay. She more likely had an anxious moment as she reports she was anxious coming in. VS and exam stable/improved (as reported).The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain, SARS-CoV-2 test
Clinical narrative: Chills, fatigue, soreness, headache; Chills, fatigue, soreness, headache; Chills, fatigue, soreness, headache; Chills, fatigue, soreness, headache; This is a spontaneous report from a contactable consumer (patient). A 26-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6199, Expiration date: Unknown), via an unspecified route of administration, in Left arm on 09Mar2021 at 03:45 (at the age of 26-years-old) as 2ND DOSE, SINGLE for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took first dose of historical vaccine bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL1283, Expiration date: Unknown), via an unspecified route of administration, in Left arm on 16Feb2021 (at the age of 26-years-old) as 1ST DOSE, SINGLE for Covid-19 immunisation. The patient did not receive other vaccine in four weeks of vaccination. The patient was not diagnosed with COVID-19, prior vaccination. The patient has been tested for COVID-19, post vaccination. On 10Mar2021, the patient had experienced chills, fatigue, soreness, headache. No treatment received for the adverse events. The patient underwent lab tests and procedures which included Nasal Swab (sars-cov-2 test): unknown on an unspecified date. The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysphagia, Dysphonia, Dyspnoea, Flushing
Clinical narrative: lightheadedness, dizziness; began to experience feeling flushed; Nausea; Difficulty breathing; Rash; Swallowing difficult; Wheezing; Throat tightness; Hoarseness; Stridor; Itching; Facial swelling; Lip swelling; Tongue swelling; This is a spontaneous report from a non-contactable other hcp.   A 66-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot Number: EN6203) as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant drugs was not reported. The patient experienced lightheadedness, dizziness, began to experience feeling flushed, nausea, difficulty breathing, rash, swallowing difficult, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling on Unspecified date. Reported as during her 15-minute waiting period after the injection, the patient began to experience feeling flushed/nausea,rash, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. Follow up response to treatment: good. Patient discharge: Stable to go home and follow up with PCP. Differential Diagnosis: Systemic reaction (hypoglycemia, hypotension, generalized rash).Greatly improved after water/snack/reclining. Therapeutic measures were taken as a result of lightheadedness, dizziness, began to experience feeling flushed, nausea, difficulty breathing, rash, swallowing difficult, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling. The outcome of the events was resolved on unspecified date.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Lip swelling, Nausea, Pruritus, Rash
Clinical narrative: lightheadedness, dizziness; began to experience feeling flushed; Nausea; Difficulty breathing; Rash; Swallowing difficult; Wheezing; Throat tightness; Hoarseness; Stridor; Itching; Facial swelling; Lip swelling; Tongue swelling; This is a spontaneous report from a non-contactable other hcp.   A 66-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot Number: EN6203) as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant drugs was not reported. The patient experienced lightheadedness, dizziness, began to experience feeling flushed, nausea, difficulty breathing, rash, swallowing difficult, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling on Unspecified date. Reported as during her 15-minute waiting period after the injection, the patient began to experience feeling flushed/nausea,rash, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. Follow up response to treatment: good. Patient discharge: Stable to go home and follow up with PCP. Differential Diagnosis: Systemic reaction (hypoglycemia, hypotension, generalized rash).Greatly improved after water/snack/reclining. Therapeutic measures were taken as a result of lightheadedness, dizziness, began to experience feeling flushed, nausea, difficulty breathing, rash, swallowing difficult, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling. The outcome of the events was resolved on unspecified date.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Stridor, Swelling face, Swollen tongue, Throat tightness, Wheezing
Clinical narrative: lightheadedness, dizziness; began to experience feeling flushed; Nausea; Difficulty breathing; Rash; Swallowing difficult; Wheezing; Throat tightness; Hoarseness; Stridor; Itching; Facial swelling; Lip swelling; Tongue swelling; This is a spontaneous report from a non-contactable other hcp.   A 66-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot Number: EN6203) as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant drugs was not reported. The patient experienced lightheadedness, dizziness, began to experience feeling flushed, nausea, difficulty breathing, rash, swallowing difficult, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling on Unspecified date. Reported as during her 15-minute waiting period after the injection, the patient began to experience feeling flushed/nausea,rash, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. Follow up response to treatment: good. Patient discharge: Stable to go home and follow up with PCP. Differential Diagnosis: Systemic reaction (hypoglycemia, hypotension, generalized rash).Greatly improved after water/snack/reclining. Therapeutic measures were taken as a result of lightheadedness, dizziness, began to experience feeling flushed, nausea, difficulty breathing, rash, swallowing difficult, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling. The outcome of the events was resolved on unspecified date.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dizziness
Clinical narrative: Vaccine-Related Anxiety (include misc. mental health); During her 15-minute waiting period after the injection, the patient began to experience light headedness; This is a spontaneous report from a non-contactable health care professional. A 66-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6206, Expiration date: Not reported), via an unspecified route of administration on an unspecified date as a 1ST DOSE, SINGLE DOSE for covid-19 immunization. The patient's medical history included wheel chair user. The concomitant medications were not reported. On an unspecified date, the patient experienced vaccine-related anxiety (include misc. mental health) and during her 15-minute waiting period after the injection, the patient began to experience light headedness, also reported that She denied rash, hives, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling. Therapeutic measures were taken as a result of adverse events was as described in physical exam and with water. The outcome of all the events were recovered on an unspecified date.  No follow-up attempts are Possible; information about lot/batch number cannot be obtained.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Headache; Nausea; This is a spontaneous report from a non-contactable Other Health Professional reported for patient. A 26-year-old female patient BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6206, Expiration date: Unknown), via an unspecified route of administration on an unknown date (at the age of 26-year-old) as 1st dose, single dose for COVID-19 immunization. Medical history included dental work and as a corrective measure took ibuprofen at 600 mg, tylenol 500 mg and applied ice pack as well on the neck. Concomitant medications included Ibuprofen at 600 mg and Tylenol at 500mg. On an unknown date, during her 15 minutes waiting period after the injection, the patient had experienced headache and nausea. She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. Patient received treatment included water, Tylenol at 500 mg, Ibuprofen at 200 mg and Pepcid at 20 mg. Symptoms was improving with medication treatments as listed. She felt comfortable going home and monitored in the bay for 25 minutes. Follow up response to treatment was good. Patient was discharge as stable to go home. She denied any concerns. Follow up with pcp as needed. Differential diagnosis reported as "red flag symptoms (CP, SOB, NVD, Visual/Neuro concerns)". The outcome of nausea was resolved, and headache was unknown.  No follow-up attempts are possible; no further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Diarrhoea, Dyspnoea, Flushing, Hyperhidrosis
Clinical narrative: This is a spontaneous report received from a non-contactable other hcp via program. A 74-year-old female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6203), via an unspecified route of administration on an unspecified date as 1st dose, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced Red flag symptoms (CP, SOB, NVD, Visual/Neuro concerns) flushed sensation and diaphoresis. During her 15 minute waiting period after the injection, the patient began to experience diaphoresis. She denied rash, hives, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. Treatment included water. Response to treatment was excellent. Patient discharged she was stable to go home and follow up with PCP. Differential Diagnosis included Red flag symptoms (CP, SOB, NVD, Visual/Neuro concerns) Flushed sensation. Pt observed for 15 minutes. Symptoms resolved. BG good and patient able to ambulate without dizziness, lightheaded, sob, cp. The outcome of event diaphoresis was unknown and all other event were recovered on an unspecified date. No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Neurological symptom, Visual impairment, Vomiting
Clinical narrative: This is a spontaneous report received from a non-contactable other hcp via program. A 74-year-old female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6203), via an unspecified route of administration on an unspecified date as 1st dose, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced Red flag symptoms (CP, SOB, NVD, Visual/Neuro concerns) flushed sensation and diaphoresis. During her 15 minute waiting period after the injection, the patient began to experience diaphoresis. She denied rash, hives, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. Treatment included water. Response to treatment was excellent. Patient discharged she was stable to go home and follow up with PCP. Differential Diagnosis included Red flag symptoms (CP, SOB, NVD, Visual/Neuro concerns) Flushed sensation. Pt observed for 15 minutes. Symptoms resolved. BG good and patient able to ambulate without dizziness, lightheaded, sob, cp. The outcome of event diaphoresis was unknown and all other event were recovered on an unspecified date. No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: he had a mild sore arm for a few hours after the vaccine dose; This is a spontaneous report from a contactable other hcp (patient, self-reporting). A 70-years-old male patient received first dose for BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number and expiration dates were not reported), via an unspecified route of administration on 29Jan2021 as 1st dose, single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced he has been unable to schedule his second dose of the vaccine and has not been contacted about it. he wants to know what to do and if it's ok to get the vaccine later than 21 days on an unspecified date and he had a mild sore arm for a few hours after the vaccine dose on 29Jan2021. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Liquid Diarrhea, 2 times. A lot of liquid and smelley; This is a spontaneous report from a contactable male consumer (patient). A 77-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6206, Expiration date: not reported), via unspecified route, administered in left arm on 09Mar2021 02:00 PM as 1st DOSE, SINGLE DOSE for COVID-19 immunisation. The patient medical history was not reported. The patient concomitant medication included valproate semisodium (DIVALPROEX) DR 500 mg and 750 mg, Rosuvastatin10 mg in two weeks of vaccination. The patient previously took glyceryl trinitrate (NITROGLYCERIN) and had allergies to it. Patient was not tested positive for covid prior of post vaccination. On 10Mar2021 07:30 am, after the vaccination, the patient experienced Liquid Diarrhoea, 2 times. A lot of liquid and smelly. Imodium was taken as treatment option. Patient had not tested positive post vaccination. The outcome of the was not recovered  No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dizziness
Clinical narrative: lightheadedness; Differential Diagnosis: Vaccine-Related Anxiety (include misc mental health); This is a spontaneous report from a non-contactable other hcp. A 79-years-old female patient received bnt162b2 (PFIZER- BIONTECH COVID- 19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot Number: EN6206) as 1st dose, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.On an unspecified date, the patient experienced lightheadedness and differential diagnosis: vaccine-related anxiety (include misc mental health). During her 30-minute waiting period after the injection, the patient began to experience lightheadedness. She denied rash, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, itching, dizziness, facial swelling, lip swelling and tongue swelling. Patient discharged, stable to go home and follow up with PCP. Differential diagnosis included vaccine related anxiety (include misc mental health) anxiety patient observed in bay area for 15 minutes. Improved and was doing well. Patient assisted out via wheelchair by husband. Patient declined help out. She felt well in standing position in the medical bay prior to discharge. Patient declined water and snacks. Follow up with PCP as needed. Therapeutic measures were taken as a result of lightheadedness and differential diagnosis: vaccine-related anxiety. Follow up response to treatment was excellent. The outcome of the events was Resolved on an unspecified date.  No follow up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Vaccination site pain
Clinical narrative: pain in the injection site; feel sick in her body, arms, and legs; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Expiration date: Not reported), via an unspecified route of administration on 07Mar2021 07:30 1ST DOSE, SINGLE DOSE as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported that she had pain in the injection site for 2-3 days, and 2 hours ago, she started to feel sick in her body, arms, and legs on an unknown date Mar2021. The patient was asking "Can I take Tylenol or Motrin for this? patient was seeking guidance on what to do for the side effects experienced. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Neck pain, Vaccination site pain
Clinical narrative: Aches and pain from neck to lower back; Aches and pain from neck to lower back; Sore left arm site of injection; This is a spontaneous report from a contactable consumer (patient). A 53-years-old female (non-pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3247 and Expiry date: Unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 09Mar2021 13:45 (at the age of 53-years-old) as 1ST DOSE, SINGLE DOSE for Covid-19 immunization. The patient medical history and concomitant medications was not reported. The patient did not have any allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. The patient was not received any treatment and diagnosed with Covid 19 and has not been tested for COVID-19 Since the vaccination. On 10Mar2021 16:00 the patient experienced aches and pain from neck to lower back and Sore left arm site of injection. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dry mouth, Dysphagia, Hypoaesthesia oral, Paraesthesia
Clinical narrative: dry mouth; tongue felt lazy; trouble swallowing; light headed/Felt faint; Starting tingling; itching; Face broke out with a rash; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received bnt162b2 (PFIZER, formulation: solution for injection, Lot Number: EN6204), via an unspecified route of administration, administered in Arm Right on 09Mar2021 15:15 (at the age of 51-years-old) as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included hypothyroidism, hypertension, pituitary tumour benign, drug hypersensitivity and food allergy from an unspecified date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received unspecified medications within 2 weeks of vaccination. The patient did not have covid prior vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 09Mar2021, the patient experienced dry mouth and tongue felt lazy for 8-10 minutes, lightheaded/felt faint for 10-12 minutes, itching for 30 minutes, trouble swallowing, tingling and face broke out with a rash. Therapeutic measures were taken as a result of the events. The patient was treated with Benadryl for these allergic reactions. Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: dry mouth; tongue felt lazy; trouble swallowing; light headed/Felt faint; Starting tingling; itching; Face broke out with a rash; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received bnt162b2 (PFIZER, formulation: solution for injection, Lot Number: EN6204), via an unspecified route of administration, administered in Arm Right on 09Mar2021 15:15 (at the age of 51-years-old) as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included hypothyroidism, hypertension, pituitary tumour benign, drug hypersensitivity and food allergy from an unspecified date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received unspecified medications within 2 weeks of vaccination. The patient did not have covid prior vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 09Mar2021, the patient experienced dry mouth and tongue felt lazy for 8-10 minutes, lightheaded/felt faint for 10-12 minutes, itching for 30 minutes, trouble swallowing, tingling and face broke out with a rash. Therapeutic measures were taken as a result of the events. The patient was treated with Benadryl for these allergic reactions. Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizzy; This is a spontaneous report from a contactable consumer (patient).   A 68-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE),  via an unspecified route of administration, administered in Arm Left on 01Mar2021 06:30 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. No other vaccine was received in four weeks. The patient previously took erythromycin and experienced drug hypersensitivity. No covid prior vaccination. No covid tested post vaccination. The patient experienced dizzy on 01Mar2021 06:45. No treatment of the event. The outcome was recovered on 01Mar2021 07:45.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise
Clinical narrative: feeling unwell; headache; Fatigue; This is a spontaneous report from a contactable consumer (patient).   A 72-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 04Mar2021 15:00 (Batch/Lot Number: EN6205) as single dose for covid-19 immunisation. First dose (Lot number: EL9261) was administered on 11Feb2021 03:15 PM, left arm. Medical history included diabetes mellitus, coronary artery disease, osteoporosis. No other vaccine was received in four weeks. Patient received unspecified concomitant medications in two weeks. No covid prior vaccination. No covid tested post vaccination.  The patient experienced feeling unwell on 05Mar2021 07:00, headache on 05Mar2021 07:00, fatigue on 05Mar2021 07:00. No treatment for the events. The events outcome was recovered.    No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Pain
Clinical narrative: Fever; chills; body aches; headache; fatigue; loss of appetite; This is a spontaneous report from a non-contactable consumer (patient).   A 47-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248) on 10Mar2021 at 14:00 at single dose via an unspecified route of administration on left arm for COVID-19 immunization. The patient received first dose of BNT162B2 on 19Fewb2021 at 12:30 pm  (lot number EL3248) on left arm. Relevant medical history included Asthma, seasonal allergies, hypertension and Shellfish allergy. Concomitant medications included lisinopril and lansoprazole. On 11Mar2021 at 09:00 am the patient experienced fever, chills, body aches, headache, fatigue and loss of appetite. No treatment was received for the events. The patient recovered from the events on 12Mar2021.    No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; chills; body aches; headache; fatigue; loss of appetite; This is a spontaneous report from a non-contactable consumer (patient).   A 47-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248) on 10Mar2021 at 14:00 at single dose via an unspecified route of administration on left arm for COVID-19 immunization. The patient received first dose of BNT162B2 on 19Fewb2021 at 12:30 pm  (lot number EL3248) on left arm. Relevant medical history included Asthma, seasonal allergies, hypertension and Shellfish allergy. Concomitant medications included lisinopril and lansoprazole. On 11Mar2021 at 09:00 am the patient experienced fever, chills, body aches, headache, fatigue and loss of appetite. No treatment was received for the events. The patient recovered from the events on 12Mar2021.    No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Loose tooth, Pain, Toothache
Clinical narrative: tooth ache; Teeth was loose; pain and aggravation; This is a spontaneous report from a contactable consumer (patient).  A 78-year-old female patient received first dose of bnt162b2 (BNT162B2; Lot number was not reported), via an unspecified route of administration on an unspecified date (at 78 years) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient was going for her 2nd shot on 12Mar2021. 2 days had a tooth ache (Mar2021) but last night seemed to stop. She did not have any tooth ache for years. Teeth was loose and had pain and aggravation (Mar2021). On 12Mar2021 she felt better, took ibuprofen on 10Mar2021 but not on 12Mar2021. Patient asked if she can get the shot. Final outcome was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Muscle spasms, Pain
Clinical narrative: chills; pains in her body; spasms; This is a spontaneous report from a contactable consumer reported for herself. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took Benadryl for hypersensitivity. The patient experienced chills, pains in her body and spasms on an unspecified date (about 3-4 day after vaccination) with outcome of unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pruritus, Sensitive skin, Vaccination site warmth
Clinical narrative: Little itchy; like sensitive skin; I felt a warm tingling sensation; was warm while sitting; This is a spontaneous report from a contactable consumer reported for herself .  A female patient of an unknown age reported that received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number unknown), into the left arm on 25Feb2021 at single dose for COVID-19 immunization. Medical history and concomitant drugs were unknown.  When she got injection, the injection site was warm while sitting for 15 minutes, she felt a warm tingling sensation, then normal like being punched in the arm feeling, how you normally feel when you get a shot. She didn't take anything, didn't sleep on it that night, the second day hurt a little more, it went a way a day or so. She just always felt like her arm didn't feel 100% right, no rash, not swollen, just feels like sensitive skin. Not pain, but as she went through the day, it was feeling more sensitive, when touched it felt a little black and blue, nothing to the eye, just doesn't feel right. Her right arm she felt nothing. She didn't know if it is a tingling sensation, it feels a little itchy, if she was wearing a shirt, it's itchy a little, she was not scratching. The outcome of the events was unknown.  Information on Lot/Batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Headache
Clinical narrative: up feeling really dizzy; bad headache; felt like she couldn't walk; This is a spontaneous report from a contactable consumer.  This female consumer (patient) of unknown age reported that received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: unknown) on 10Mar2021 at single dose for COVID-19 immunization. Medical history and concomitant drugs were unknown. The next day she woke up feeling really dizzy, like a really bad headache, felt like she couldn't walk. At the time of reporting the outcome was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash macular, Urticaria
Clinical narrative: arm was a little sore; breaking out in hives; itching and little blotches on her skin; itching and little blotches on her skin; This is a spontaneous report from a contactable consumer.  This 68-year-old female consumer (patient) reported that received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number unknown),  on Mar2021 at single dose for COVID-19 immunization. medical history included she is allergic to pollen. She felt all right after vaccination. Her arm was a little sore.  However, since unknown date in Mar2021, she's been "breaking out in hives". She has "bumps on her arm and neck". She stated she feels all right but noticed she's "itching and little blotches on her skin, around her neck and some on her thighs". She took Benadryl. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Paraesthesia, Paraesthesia oral
Clinical narrative: Left side of face and tongue got numb and tingly; Left side of face and tongue got numb and tingly; Left side of face and tongue got numb and tingly; Left side of face and tongue got numb and tingly; This is a spontaneous report from a contactable consumer (patient) via a 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 10Mar2021 (Batch/Lot number was not reported) (at the age of 63-years-old) as 1st dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient stated that within a few minutes after receiving the vaccine, the left side of her face and tongue got numb like it was treated with Novocaine. Her medical doctor (MD) told her to pre-treat her second dose (scheduled for 31Mar2021) with Tylenol and Benadryl. On 12Mar2021, the patient reported that she received the first COVID vaccine on 10Mar2021 and 25 minutes after, her left side of face and tongue got numb and tingly. It is almost back to 100% now of feeling normal. Her healthcare professional (HCP) said to take Benadryl before the second COVID vaccine. She is making sure that this will be ok to do. The outcome of the events was recovered on 12Mar2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: feeling "tired"; This is a spontaneous report from a non-contactable consumer (patient).  A female consumer of unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 10Mar2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were unknown. The patient felt very tired on unknown date. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: lightheadedness; not myself; This is a spontaneous report from a contactable consumer (patient). A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), on 11Mar2021 at 1st dose, single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications were not reported. The patient felt fine on the day of the first vaccine dose. On 12Mar2021, he felt not himself, lightheadedness. The outcome of the events was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot been obtained.